Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.58
+0.24 (3.79%)
Oct 15, 2026, 4:00 PM EDT - Market closed
Cartesian Therapeutics Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Cartesian Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $33.67. The average 1-year stock price forecast is 411.70% higher than the current stock price, while the lowest is $16 (+143.16%) and the highest is $44 (+568.69%).
Price Target: $33.67 (+411.70%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cartesian Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +279.94% | Sep 30, 2026 |
| BTIG | BTIG | Buy Maintains $44 | Buy | Maintains | $44 | +568.69% | Sep 30, 2026 |
| Needham | Needham | Buy Maintains $40 | Buy | Maintains | $40 | +507.90% | Sep 29, 2026 |
| Wedbush | Wedbush | Buy Maintains $38 | Buy | Maintains | $38 | +477.51% | Aug 18, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $16 | Buy | Reiterates | $16 | +143.16% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
419.14K
from 2.80M
Decreased by -85.01%
Revenue Next Year
285.71K
from 419.14K
Decreased by -31.83%
EPS This Year
-2.78
from -4.99
EPS Next Year
-3.81
from -2.78
EPS and Forward PE are based on non-GAAP adjusted numbers.